Wells Fargo maintains Clorox at Equal-Weight, raises price target to $90 from $85

What happened

Wells Fargo kept its Equal-Weight rating on Clorox and raised its price target to $90 from $85, a 5.9% increase. The new target is roughly in line with the Nov 2 close of $89.90.

Confirmed

Global impact / market context

A higher price target means Wells Fargo sees slightly more value in Clorox shares, but an Equal-Weight rating signals the stock looks fairly priced rather than cheap. That can shape how investors position money in consumer staple companies.

Analyst inference

Recent analyst targets for Clorox range from $80 to $99, with some firms holding cautious Underweight or Neutral views. Wells Fargo's $90 target sits in the middle, suggesting analysts broadly expect limited share price gains.

Analyst inference

What to watch

1. Wells Fargo raised its Clorox price target but kept an Equal-Weight rating, so watch whether other analysts change their ratings or targets in response. Confirmed
2. Investors could compare each new analyst price target and rating against the $80 to $99 range from recent notes to judge whether views are improving or worsening. Proposed
3. Watch Clorox's future earnings and sales reports, because a higher price target implies analysts expect profit and revenue trends to support a slightly higher share value. Analyst inference

Evidence

• Original source link unavailable